Table 29.1: Number of Cancer Deaths and DALYs Lost to Cancer, by World Bank Region and Country Income Level, 2001
Number of Cancer Deaths and DALYs Lost to Cancer, by World Bank Region and Country Income Level, 2001 | East Asia and the Pacific | Europe and Central Asia | Latin America and the Caribbean | Middle East and North Africa | South Asia | Sub-Saharan Africa | Low-and middle-income countries | High-income countries | | Cancer site | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | Deaths | DALYs lost | | Trachea, bronchus, and lung cancers | 387,000 | 5,333,000 | 165,000 | 2,323,000 | 55,000 | 728,000 | 20,000 | 283,000 | 129,000 | 1,807,000 | 15,000 | 225,000 | 771,000 | 10,701,000 | 456,000 | 5,397,000 | | Stomach cancer | 442,000 | 6,134,000 | 101,000 | 1,376,000 | 57,000 | 735,000 | 18,000 | 252,000 | 45,000 | 629,000 | 33,000 | 487,000 | 696,000 | 9,616,000 | 146,000 | 1,628,000 | | Liver cancer | 373,000 | 5,923,000 | 28,000 | 379,000 | 21,000 | 277,000 | 9,000 | 138,000 | 27,000 | 464,000 | 46,000 | 762,000 | 505,000 | 7,945,000 | 102,000 | 1,223,000 | | Esophageal cancer | 232,000 | 3,217,000 | 21,000 | 288,000 | 16,000 | 215,000 | 5,000 | 72,000 | 80,000 | 1,116,000 | 24,000 | 343,000 | 380,000 | 5,252,000 | 58,000 | 702,000 | | Colorectal cancer | 159,000 | 2,334,000 | 96,000 | 1,290,000 | 37,000 | 485,000 | 10,000 | 164,000 | 35,000 | 499,000 | 20,000 | 291,000 | 357,000 | 5,060,000 | 257,000 | 3,175,000 | | Breast cancer | 93,000 | 1,730,000 | 63,000 | 1,058,000 | 37,000 | 642,000 | 14,000 | 273,000 | 76,000 | 1,246,000 | 34,000 | 574,000 | 317,000 | 5,527,000 | 155,000 | 2,509,000 | | Mouth and oropharyngeal cancers | 66,000 | 1,064,000 | 27,000 | 426,000 | 14,000 | 204,000 | 5,000 | 78,000 | 140,000 | 2,020,000 | 19,000 | 284,000 | 271,000 | 4,078,000 | 41,000 | 576,000 | | Cervix uteri cancer | 47,000 | 805,000 | 19,000 | 356,000 | 26,000 | 494,000 | 5,000 | 93,000 | 83,000 | 1,423,000 | 38,000 | 627,000 | 218,000 | 3,799,000 | 17,000 | 319,000 | | Lymphomas and multiple myeloma | 42,000 | 753,000 | 23,000 | 375,000 | 24,000 | 383,000 | 12,000 | 232,000 | 82,000 | 1,401,000 | 34,000 | 622,000 | 216,000 | 3,770,000 | 115,000 | 1,362,000 | | Leukemia | 76,000 | 1,652,000 | 27,000 | 462,000 | 22,000 | 444,000 | 14,000 | 307,000 | 38,000 | 851,000 | 14,000 | 245,000 | 190,000 | 3,965,000 | 73,000 | 919,000 | | Prostate cancer | 16,000 | 164,000 | 25,000 | 283,000 | 37,000 | 340,000 | 6,000 | 64,000 | 21,000 | 210,000 | 40,000 | 416,000 | 145,000 | 1,479,000 | 119,000 | 1,212,000 | | Pancreatic cancer | 37,000 | 544,000 | 35,000 | 481,000 | 20,000 | 248,000 | 4,000 | 55,000 | 13,000 | 176,000 | 8,000 | 117,000 | 117,000 | 1,621,000 | 110,000 | 1,232,000 | | Bladder cancer | 30,000 | 348,000 | 24,000 | 300,000 | 9,000 | 100,000 | 15,000 | 214,000 | 30,000 | 408,000 | 10,000 | 133,000 | 117,000 | 1,504,000 | 59,000 | 670,000 | | Ovarian cancer | 25,000 | 464,000 | 21,000 | 350,000 | 9,000 | 152,000 | 2,000 | 42,000 | 21,000 | 327,000 | 9,000 | 152,000 | 86,000 | 1,488,000 | 46,000 | 651,000 | | Corpus uteri cancer | 8,000 | 175,000 | 17,000 | 349,000 | 12,000 | 254,000 | 1,000 | 22,000 | 4,000 | 66,000 | 3,000 | 41,000 | 44,000 | 908,000 | 27,000 | 586,000 | | Melanoma and other skin cancers | 5,000 | 66,000 | 11,000 | 160,000 | 7,000 | 97,000 | 1,000 | 19,000 | 3,000 | 41,000 | 8,000 | 118,000 | 35,000 | 501,000 | 30,000 | 409,000 | | Other malignant neoplasms | 104,000 | 1,640,000 | 123,000 | 1,901,000 | 82,000 | 1,263,000 | 26,000 | 440,000 | 26,000 | 1,444,000 | 55,000 | 844,000 | 490,000 | 7,538,000 | 257,000 | 3,316,000 | | Total (all malignant neoplasms) | 2,142,000 | 32,346,000 | 826,000 | 12,157,000 | 485,000 | 7,061,000 | 167,000 | 2,748,000 | 853,000 | 14,128,000 | 410,000 | 6,281,000 | 4,955,000 | 74,752,000 | 2,068,000 | 25,886,000 |
Mathers and others 2006.
Note: For an explanation of how DALYs are computed, see chapter 15 of this volume. |
< Back to Chapter Summary Page
Chapter Sections
Figures
Tables
-
29.1
Number of Cancer Deaths and DALYs Lost to Cancer, by World Bank Region and Country Income Level, 2001
-
29.2
Estimates of the Cost-Effectiveness of Colorectal Cancer Screening Interventions, United States (cost-effectiveness ratios expressed as 2000 US$/YLS)
-
29.3
Economic Outcomes of Once-in-a-Lifetime Cervical Cancer Screening Programs, Brazil, Madagascar, and Zimbabwe
-
29.4
Estimates of the Cost-Effectiveness of Breast Cancer Screening Every Two Years for Women in Selected Developed Countries
-
29.5
Cost-Effectiveness Analysis of Various Breast Cancer Screening Programs Involving Either CBE or Mammography for a Population of 1 Million Women, Compared with No Screening, India
-
29.6
Sensitivity Analysis for Changes in Breast Cancer Incidence and Attendance Rate, CBE Sensitivity, No Palliative Treatment, and Alternative Cost Estimates for a Population of 1 Million Women, Compared with No Screening, India
-
29.7
Cost-Effectiveness of Selected Breast Cancer Treatments for a Hypothetical Cohort of 45-Year-Old Premenopausal Women with Early-Stage Breast Cancer, United States (cost in 2000 US$/quality-adjusted life year)
|
